Insight Guide

First-in-Human Development Strategies

Format: PDF file | Document type: Insight Guide | Promoted Content

This content is provided by Catalent, and any views and opinions expressed do not necessarily reflect those of

First-in-Human Development Strategies

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate. Drug developers must consider many factors when positioning a preclinical drug candidate to succeed in first-in-human clinical trials.

This executive summary will map out the preformulation studies needed to create the best development path for a drug candidate and describe oral and injectable clinical formulation options for short- and long-term success.

Latest content from Catalent

Related resources from Catalent

Show more

Supplier info centre